Vext Science Inc (VV5) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vext Science Inc (VV5) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.26 Million ≈ $1.47 Million USD) by net assets (€68.41 Million ≈ $79.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Vext Science Inc for the company's overall valuation and market capitalisation.
Vext Science Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Vext Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Vext Science Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vext Science Inc ranked by their cash flow conversion efficiency. Explore Vext Science Inc (VV5) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rand Capital Corp
NASDAQ:RAND
|
0.009x |
|
KMH Hitech Co. Ltd
KQ:052900
|
0.058x |
|
Destini Bhd
KLSE:7212
|
-0.126x |
|
Kronologi Asia Bhd
KLSE:0176
|
-0.003x |
|
Yoo Sung Ent
KO:002920
|
0.030x |
|
Level Biotechnology
TWO:3118
|
0.021x |
|
Elektrocieplownia Bedzin
WAR:BDZ
|
0.159x |
|
Anli International Co Ltd
TWO:5223
|
0.003x |
Annual Cash Flow Conversion Efficiency for Vext Science Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of Vext Science Inc from 2017 to 2024. View VV5 share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €75.74 Million ≈ $88.54 Million |
€3.29 Million ≈ $3.84 Million |
0.043x | -6.79% |
| 2023-12-31 | €94.98 Million ≈ $111.04 Million |
€4.42 Million ≈ $5.17 Million |
0.047x | -43.43% |
| 2022-12-31 | €71.92 Million ≈ $84.08 Million |
€5.92 Million ≈ $6.92 Million |
0.082x | -58.13% |
| 2021-12-31 | €59.39 Million ≈ $69.44 Million |
€11.68 Million ≈ $13.66 Million |
0.197x | +130.49% |
| 2020-12-31 | €36.31 Million ≈ $42.45 Million |
€3.10 Million ≈ $3.62 Million |
0.085x | +656.98% |
| 2019-12-31 | €25.67 Million ≈ $30.01 Million |
€-393.31K ≈ $-459.82K |
-0.015x | -110.81% |
| 2018-12-31 | €17.00 Million ≈ $19.88 Million |
€2.41 Million ≈ $2.82 Million |
0.142x | -33.46% |
| 2017-12-31 | €8.77 Million ≈ $10.26 Million |
€1.87 Million ≈ $2.19 Million |
0.213x | -- |
About Vext Science Inc
Vext Science, Inc., through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company al… Read more